Search

Your search keyword '"Wiese, L"' showing total 298 results

Search Constraints

Start Over You searched for: Author "Wiese, L" Remove constraint Author: "Wiese, L"
298 results on '"Wiese, L"'

Search Results

2. SARS-CoV-2 vaccine-induced antibodies protect against Omicron breakthrough infection

3. Existing Data Sources for Clinical Epidemiology: The Danish Study Group of Infections of the Brain Database (DASGIB)

4. Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration

5. SARS-CoV-2 vaccine-induced antibodies protect against Omicron breakthrough infection

6. Notes on the crab spider Phaenopoma nigropunctatum O. Pickard-Cambridge, 1883 from South Africa (Araneae: Thomisidae). SANSA Newsletter 46(2023): 7–9

7. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy

10. SANSA Eastern Cape surveys: A checklist of the spiders (Arachnida, Araneae) of Jeffreys Bay, South Africa. SANSA Newsletter 45 (2023): 19–28

11. First record of the crab spider Diaea albicincta Pavesi, 1883 from South Africa (Araneae: Thomisidae).SANSA Newsletter 45 (2023): 17-18

12. First record of Leucauge argyrescens Benoit, 1978 from South Africa (Araneae: Tetragnathidae)

13. More on the crab spider Phrynarachne melloleitaoi Lessert, 1933 from South Africa (Araneae: Thomisidae)

14. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy: A multinational prospective cohort study

15. Incidence of cancer and overall risk of mortality in individuals treated with raltegravir‐based and non‐raltegravir‐based combination antiretroviral therapy regimens

16. The extent of B‐cell activation and dysfunction preceding lymphoma development in HIV‐positive people†

17. Prevalence and Outcomes for Heavily Treatment-Experienced Individuals Living With Human Immunodeficiency Virus in a European Cohort

18. The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study

20. Tocilizumab in patients hospitalised with COVID-19 pneumonia: Efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA)

21. Prognostic and Predictive Biomarkers in Patients With Coronavirus Disease 2019 Treated With Tocilizumab in a Randomized Controlled Trial

22. SANSA Eastern Cape surveys: A checklist of the spiders (Arachnida, Araneae) of Thyspunt, South Africa

23. Observational cohort study of rilpivirine (RPV) utilization in Europe

24. HCV reinfection after HCV therapy among HIV/HCV-coinfected individuals in Europe

25. Notes on the rare nursery-web spider Walrencea globosa Blandin, 1979 in South Af-rica (Araneae: Pisauridae)

26. Gender differences in the use of cardiovascular interventions in HIV‐positive persons; the D:A:D Study

27. Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials.

28. Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials

29. Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials

30. Establishing a hepatitis C continuum of care among HIV/hepatitis C virus-coinfected individuals in EuroSIDA

31. Clinical Outcomes in Persons Coinfected With Human Immunodeficiency Virus and Hepatitis C Virus:Impact of Hepatitis C Virus Treatment

32. Design for sustained wellbeing through positive activities—a multi-stage framework

33. Long‐term effectiveness of recommended boosted protease inhibitor‐based antiretroviral therapy in Europe

36. Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens

37. Uptake and effectiveness of two-drug compared with three-drug antiretroviral regimens among HIV-positive individuals in Europe

38. Establishing a hepatitis C continuum of care among HIV/hepatitis C virus-coinfected individuals in EuroSIDA

39. Uptake and effectiveness of two-drug compared with three-drug antiretroviral regimens among HIV-positive individuals in Europe

40. Activities as a Gateway to Sustained Subjective Well-Being Mediated by Products

43. Abacavir usage patterns and hypersensitivity reactions in the EuroSIDA cohort

Catalog

Books, media, physical & digital resources